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Abstract— In an ever evolving and highly competitive mobile 
health application market, software developers and companies 
face the daunting challenge to streamline their development 
methods to be able to obtain and correctly interpret customer 
demands, in order to reduce wasted resources and reevaluate and 
improve their products to stay competitive within this volatile 
industry. This exploratory case study aims at identifying how 
mHealth developers deploy their products by applying build-
measure-learn principles and how frequently a new minimum-
viable-product is released; along with analyzing which factors that 
triggers the continuous development of their products, if any 
significant amount of changes are driven by user-experience 
issues, stability enhancements, legislative requirements, 
compatibility demands or emerging technological possibilities 
providing opportunities for extended functionality; as well as 
investigating which basic functionality that should be considered 
vital to implement in an initial version of a minimum-viable-
product in this field. 
Keywords— minimum-viable-product; mvp; build-measure-
learn; bml; lean software development; mhealth; ehealth; mobile 
application development; medical software; release frequency; 
continuous evolution 
I.  INTRODUCTION 
A. Purpose 
It should be considered highly significant that supplying 
software development companies, active within any product 
field, has the ability to continuously deliver their products in 
order to capture customer demands and thus reducing waste of 
valuable resources in terms of time and money spent on 
implementing unwanted features and developing undesirable 
products [2]. This exploratory case study [15] aims to investigate 
how often mHealth products, packaged in the form of 
smartphone mobile health applications, are continuously 
updated and how the release and change frequency differs 
compared to other mobile application domains. Furthermore, we 
wish to identify the underlying causes driving the changes 
implemented in new versions of mobile health applications as 
well as which features that are necessary to include in a first 
version of a new mHealth product when initially released to the 
market. With this information we attempt to identify how ‘Lean 
start-up’ principles such as the build-measure-learn process is 
realized together with what functionality is required to deploy a 
minimum viable product (MVP) within the mobile health 
applications domain [3][4].  
By exploring what triggers the development of a new 
minimum viable product in the current mHealth market, in terms 
of which the most common set of new features and possible 
constraints on their continuous deployment are; the results of 
this study will be of interest for software engineers active within 
mobile health startup projects as well as software developers and 
business analysts operating in other parts of the eHealth domain, 
who wish to extend their current products to the mobile health 
applications market. 
This investigation should be considered evidently important 
due to the growing size of the current mobile applications market 
[7] and the, as today, more than ever relevant utilization of 
information technology within the eternal human need of 
medical assistance [8].  
B. Research Questions 
• RQ 1: How frequent is the continuous development 
of a MVP of a mobile health application? 
SRQ 1.1: Do the release frequency of 
minimum viable products differ between 
mobile health applications of different 
purposes?  
We want to find out how often new 
versions of a minimum viable product of 
mobile health applications are released to 
the market and if the frequency differs 
between various mHealth applications 
targeted at different usage areas. 
SRQ 1.2: Do the release frequency of 
minimum viable products differ between 
mobile health applications and mobile 
applications of other domains? 
As with the former question, we want to 
find out how often new versions of a 
minimum viable product are released to 
the market within mHealth applications in 
general, but compared to other mobile 
applications of completely different 
purposes. 
o SRQ 1.3: Do the change frequency of 
minimum viable products differ between 
mobile health applications of different 
purposes?  
With this question we want to find out 
how often changes are integrated into a 
new released version of a minimum viable 
product of mobile health applications and 
if the frequency differs between various 
mHealth applications targeted at different 
usage areas. 
o SRQ 1.4: Do the change frequency of 
minimum viable products differ between 
mobile health applications and mobile 
applications of other domains? 
As with the previous question, we want to 
find out how often changes are integrated 
into a new released version of a minimum 
viable product within mHealth 
applications in general, but compared to 
other mobile applications of completely 
different purposes. 
With these questions we wish to measure the frequency of 
continuous evolution of mobile health applications, i.e. how 
often an updated version of the minimum viable product is 
developed and deployed to the market. Additionally, we also 
wish to identify if mobile health applications are any different in 
terms of frequency of continuous development and deployment, 
compared to completely different mobile application domains. 
• RQ 2: Which factors drive the development of 
updating a MVP of a mobile health application? 
o SRQ 2.1: Are the factors of the change of 
the minimum viable product rooted in 
user-experience issues, stability 
enhancements, legislative requirements, 
compatibility demands or emerging 
technological possibilities providing 
opportunities for extended functionality? 
We wish to identify, label and categorize 
the driving factors of the change for a 
minimum viable product in the mHealth 
domain. 
o SRQ 2.2: Do the factors of the change of 
the minimum viable product differ 
between mobile health applications of 
different purposes? 
In addition to finding out why a change is 
necessary for a minimum viable product, 
we want to investigate if any differences 
exist, regarding these findings, between 
various mHealth applications targeted at 
different usage areas. 
o SRQ 2.3: Do the factors of the change of 
the minimum viable product differ 
between mobile health applications and 
mobile applications of other domains?  
As with the previous question, we want to 
find out if any differences exist between 
the driving factors of change of a 
minimum viable product within mHealth 
applications in general, compared to other 
mobile applications of completely 
different purposes. 
With these questions we strive to identify the underlying 
causes of continuous evolution of mobile health applications, i.e. 
what are the main reasons for deploying an updated version of 
the minimum viable product. Additionally, we also wish to 
identify if mobile health applications are any different in terms 
of factors driving continuous development and deployment, 
compared to completely different mobile application domains.     
• RQ 3: What are the most common set of Minimum 
Viable Features (MVF) for a mobile health 
application? 
o SRQ 3.1: Do the set of core Minimum 
Viable Features differ between mobile 
health applications of similar purposes? 
We want to find out if there are any 
differences of which main features that 
must be initially implemented in mobile 
health applications, targeted at the same 
usage areas, from the first version release 
in order for the product to be considered 
viable. 
o SRQ 3.2: Do the set of core Minimum 
Viable Features differ between mobile 
health applications of different purposes? 
Following the previous question, we want 
to find out if there are any differences of 
which main features that must be initially 
implemented in mobile health 
applications, targeted at different usage 
areas, from the first released version in 
order for the product to be considered 
viable. 
o SRQ 3.3: Do the set of core Minimum 
Viable Features differ between mobile 
health applications and mobile 
applications of other domains? 
In addition to the two previous research 
questions, we want to find out if any 
differences exists of which main features 
that must be initially implemented in the 
first version release of mHealth 
applications compared to other mobile 
application domains in order for the 
product to be considered viable. 
The purpose with these research questions were to determine 
which core features that are most commonly included in an 
initial MVP of different types of mobile health applications. We 
considered this to be relevant since we wanted to investigate if 
any general differences exist between health applications 
developed for both different and similar purposes, as well as 
between mHealth applications in general and other mobile 
application domains, in terms of core functionality when 
developing an initial minimum viable product. 
II. THEORETICAL BACKGROUND 
A. Minimum Viable Product & Build-Measure-Learn 
Many companies such as Google, Microsoft and Facebook 
has adopted an agile software development approach where both 
requirements and solutions develop gradually through 
collaborating self-organized and cross-functional teams [1]. In 
order to stay competitive on the software market it is vital that 
companies operating in this field has the ability to provide 
continuous delivery in order to bring and maintain customer 
value [2]. A minimum viable product (MVP) is in most cases the 
earlier versions of the product that is released for the market to 
obtain end-user opinions. The MVP is characterized by only 
having the minimum set of features, i.e. becoming viable for the 
end-users in order to solve the problem it was designed for [3].  
  
 
Figure 1. A representation of a minimum viable product, the intersection 
between the definitions minimum and viable [17]. 
When developing mobile applications there are companies 
that are applying the concept called “pivot or persevere” which 
means that before planning the next version of a mobile 
application release, a decision is made regarding to continue on 
the same path (persevere) or change the strategy (pivoting). In 
order to realize a MVP, companies utilize an activity called 
build-measure-learn (BML). First you build a MVP, then 
measure if the MVP leads to an advancement of the product, and 
lastly you learn by drawing a conclusion of the measurement of 
the MVP and decide whether to pivot or persevere. Using the 
aforementioned strategy enables companies to keep iteration 
momentum as well as ensuring the right strategy for their next 
version of the application by applying BML [4]. 
 
Figure 2. An illustration of the build-measure-learn process cycle [16]. 
B. mHealth 
Electronic Health (eHealth) is a term that is used to describe the 
transmission, storage and retrieval of digital data in the health 
sector, combining electronic communication with information 
technology [5]. The term Mobile Health (mHealth) basically 
extends eHealth by describing such functionality utilized by the 
use of mobile smartphones and other mobile devices. 
Additionally, it is further defined as a concept including 
capturing, analyzing, processing and transmitting information 
related to health collected by sensory information or user input 
from portable devices running the intended and relevant mobile 
applications [6].  
  
Figure 3. An illustration of the mHealth concept and what it covers [18]. 
C. The Current Mobile Applications Market 
A significant increase of mobile applications has emerged 
since the year of 2000. As there are currently over 1 billion 
smartphones and more than 100 million tablets used daily 
around the world, indications of a big and growing market for 
mobile health applications are implied which should essentially 
be considered as a valuable possibility for new usage areas and 
business opportunities for mobile application developers, 
private smartphone-users interested in monitoring their health 
conditions, as well as medical patients, entrepreneurs and 
professionals from the entire healthcare industry [7]. As of 2015 
there are approximately 165 000 mobile health applications 
running world-wide [8]. 
D. Lean Software Development 
The Lean development (LD) approach stems from the 
Japanese automotive manufacturer Toyota and was developed 
during the 1950s, it was originally called Toyota Production 
System (TPS) and it was developed in order to specify value, as 
well as coordinate the value-adding actions, execute these 
actions upon request without interruption and the aim of 
improving continuously [12]. A customized principle of this 
approach was presented in the book “Lean Software 
Development: An Agile Toolkit” by Mary Poppendieck and 
Tom Poppendieck (2003). This book presented how to apply 
accepted lean practices and transfer those to agile software 
development. Accordingly, there are seven steps to achieve this:  
1. Eliminate waste - find out exactly what the 
customer wants, everything else is considered 
waste.  
2. Amplify learning - Try out several solutions in 
order to find the best solution  
3. Decide as late as possible - In fast evolving markets 
it is better to have the option to change rather than 
decide early on, facts are better than speculations.  
4. Deliver as fast as possible - If the speed is not up to 
par, you cannot delay decisions nor get reliable 
feedback. Since the development cycle usually 
consists of: design, implement, feedback and 
improvement, more can be learned the shorter those 
development cycles are. Having speed also ensures 
that you deliver value to your customer today when 
they need it and not tomorrow.  
5. Empower the team - Involves the developers of the 
specifications of the technical decisions in order to 
establish a good product, let the developers make 
the decisions instead since they know best because 
they are the ones doing the software development. 
This is realized by having daily meetings, visible 
charts, continuous integration and testing of the 
software which gives the developers the tools to 
communicate and make decisions on their own of 
what needs to be done. This enables to release 
refined versions of working software in iterations.  
6. Build integrity in - When the software does what 
the intended users expects it to do, furthermore, it 
should then run smoothly and also have the ability 
to evolve meaningful into the future as well as has 
a high rate of usability and purposefulness.   
7. See the whole - when developing a product, it is 
common that the person that has expertise in a 
certain area of the development tries to allocate 
most resources performance-wise to that area (e.g., 
backend or frontend), making the overall 
performance of the product suffer [13]. 
E. MVP and Release Frequency 
In today’s development of mobile applications, it is vital that 
the delivery of those applications are developed and delivered as 
fast as possible to quickly generate a return of the financial 
investment made. Therefore, Lean approaches has been adopted 
for the development of minimum viable products (MVP) which 
focus and prioritize a core set of features of each iteration of the 
mobile application [9][10]. Hence, the release frequency of these 
applications does impact on not only financial gains, but factors 
such as product quality and customer satisfaction [11]. 
III. METHOD 
A. Data Collection 
In the process of gathering the data necessary to answer our 
research questions we used Apple iTunes as a library to search 
for mobile applications based on a specific filtering criteria. We 
decided to collect data regarding different applications targeted 
at a variety of medical and health-related conditions, namely; 
diabetes, diet/calorie guidance, woman’s health and pregnancies 
and a few other miscellaneous medical usages. Additionally, we 
decided to inspect the version history of applications from other 
domains, such as from financial/banking services, fitness 
coaching, entertainment and utilities, in order to map out if any 
general differences exist regarding release of new minimum 
viable products between our samples of mobile health 
applications and the other mobile apps. We exclusively selected 
applications with a full version history available, which enabled 
us to compare and study the changes of each version of the 
application and deduct the minimum viable product, its core 
features and reasons for continuous deployment.  
B. Data Analysis - How frequent is the continuous 
development of a MVP of a mobile health application and 
which factors drives it? 
In order to get a good overview of the mobile applications 
from the various domains we created a data spreadsheet which 
enabled us to document and categorize those applications in a 
systematic way. The classifications consisted of: 
• App domain 
The domain from which the application belongs to 
was classified as either usage related to specific 
medical health conditions, such as: diabetes, 
diet/calories, woman’s health and pregnancy, or 
other miscellaneous medical domains with 
applications we found interesting for this study; and 
non-medical related domains, such as tool/utility, 
entertainment, finance and fitness. Although 
fitness-related apps could be associated to health-
related usage, we decided to distinct this category 
from the other medical/health apps we used in this 
study since we do not consider it to be directly 
related to any medical condition and should thus 
not be included in our interpretation of the concept 
of mHealth applications.   
• Date of first release of MVP 
The date of the initial release of the first MVP for 
every application, which was not only necessary in 
order to estimate the lifetime, e.g. for how long an 
application has been available on the market, but 
also to understand how the perspective of time 
could affect any differences between various 
applications minimum viable features dependent on 
current technological possibilities.  
• Date of latest version 
The date of the latest released version of the 
application, equally necessary as the date of the first 
release, to estimate for how long an application has 
existed for customer usage.  
• Lifetime 
The total lifetime in days that an application has 
existed, necessary to understand how frequently the 
MVP has been updated into a new market release. 
• Number of versions 
The total amount of MVP versions released for 
every application, necessary in order to measure the 
release ratio and average amount of changes 
implemented in every release of a new MVP. 
• Average days between new releases 
A representation of how often a new MVP version 
has been released to the market. 
• Release ratio 
A new version is released when there have been one 
or more changes implemented into the mobile 
application and there is an increased version 
number, e.g. “Version 2.0” from the previous 
“Version 1.9”. For each application we divided the 
total amount of released versions with the number 
of days of its existing lifetime. Using the following 
formula: ! = 	 $%& − %( 
 
Where V = The total number of released versions, 
D1 = The date of the first released MVP and D2 = 
The date of the latest released MVP: A higher 
figure represents a more frequent continuous 
delivery of released versions of a MVP. This gave 
us a value we refer to as a “release ratio”, a figure 
representing how often a new release have been 
historically deployed, and thus giving us insight in 
how often a new minimum viable product is 
developed and delivered to the market. 
 
Figure 4. An example of a complete version release. 
• No of changes 
The total amount of changes implemented during 
the full lifetime of an application. This data was 
necessary in order to measure the amount of 
changes that is implemented on average in every 
release of a new MVP. 
• Change/Release ratio (Average amount of changes 
per new release) 
We consider any altering of the mobile application 
to be a change compared to the previous version. 
We estimated the mean amount of changes per each 
new release of every application. This ratio value 
gave us insight in how many changes are realized 
in every iteration of deploying a new minimum 
viable product. Using the following formula: ! = 	)$ 
 
Where C = The total number of implemented 
changes and V = The total number of released 
versions: A higher figure represents a higher mean 
amount of changes implemented in newly released 
versions of the MVP. 
 
Figure 5. An example of a change implemented within a release. 
• Driving cause of the change 
We analyzed every change made in each updated 
version of the minimum viable product in an 
attempt to identify the main causes and purpose for 
the change. Every change was then classified to be 
rooted in at least one of the seven categories 
specified below. We later found out that some 
changes did not fit into any of the following 
classifications and if the cause were insignificant to 
our research, we classified it into the miscellaneous 
category “Other”. Additionally, some changes were 
broad enough to be considered to relate to more 
than one purpose. The different classifications we 
used to analyze the drivers of the change were: 
o User-Experience related 
If the change affects the user's experience 
of the application in any way such as a 
new graphical user interface, updated 
FAQ, different colors or extended 
customizability, etc. 
  
Figure 6. An example of a change driven by user-
experience improvements. 
o Performance optimization 
A vital part of an application is great 
performance, whether it is a more 
effective calculating algorithm or 
utilizing the hardware in a more efficient 
way. Speed and performance is highly 
significant and every increase of it adds 
value and advantages to the user in the 
form of saved time and efficiency when 
conducting actions and interactions 
within the application. Every change that 
were considered to be related to 
performance optimization were classified 
to this category. 
  
Figure 7. An example of a change driven by 
performance optimization. 
o Bug fix/Stability enhancements 
The last thing anyone using software 
wants is an unexpected crash, making bug 
fixes and stability enhancements critical 
in order to maintain a good user-
experience and reputation of the 
application. Every change related to bug 
fixes and stability enhancements were 
classified to this category. 
 
Figure 8. An example of changes classified as bug 
fixes/stability enhancements. 
o Legislative causes 
This classification was supposed to be 
used for changes that had been 
implemented because of legislative 
causes. Furthermore, the classification 
was included based on our initial 
assumption that there might be judicially 
regulatory demands and constraints on 
applications interacting with human 
health conditions. 
o Compatibility 
This classification specifies changes with 
a sole purpose to ensure that the 
application runs as intended by the 
developer and supports the current mobile 
platform operative system and other 
features that the application requires to 
run properly. 
 
Figure 9. An example of a change related to 
compatibility improvements.  
o New features already possible with 
previous technology 
Changes introducing and utilizing new 
features that had been supported and 
possible with previous technology but not 
yet been implemented and taken 
advantage of within the application, were 
classified to this category. 
 
Figure 10. An example of a change classified as a 
new feature already possible with existing 
technology. 
o New features made possible with new 
technology 
As opposed to the previous classification, 
these were changes utilizing and taking 
advantage of new features that had been 
introduced and enabled by the use of new 
technology, either software- or hardware-
related, and implemented within the 
application. 
 
Figure 11. An example of a change classified as a 
new feature made possible with new technological 
opportunities. 
o Other 
This is a category that we only used for 
changes that were of minor significance to 
our research and could not be allocated to 
any other cause of change categories. 
 
Figure 12. An example of a change unrelated to the 
other classifications and less significant to our topic 
of research. 
These classifications have provided us with the 
possibility to understand what the drivers of 
change of the MVP are for mHealth applications 
and other different mobile applications along with 
information of how often a new version of a MVP 
is released in the different domains. 
C. Data Analysis - What are the most common set of Minimum 
Viable Features (MVF) for a mobile health application? 
In order to obtain the necessary results to answer this 
research question our initial plan was to further investigate the 
medical applications used in our sample to identify which set of 
features were provided in the current MVP and subtract them 
off if they were discovered to be implemented at any given 
point of time documented in the available version history. By 
using the following formula: * = {,	 	, ∈ . ∧ , ∉ {1 − 12}}		
 
Where x represents the set of features included in the 
application a, but not included in any of the releases r other than 
the initially released version r0. This would give us a set of core 
minimum features for every application and the next step would 
be to compare these features between the other applications of: 
the same purpose i.e. providing usefulness for the same medical 
conditions; those with a different medical purpose and; the 
applications of totally different domains. During this phase of 
our research we realized that the collected sample would be 
insufficient to analyze in order to obtain the desired results to 
answer these research questions. This was however unfeasible 
due to various constraints that we discovered, generally 
identified as: 
• The initial MVP deployment of the different 
applications were spread during a too large span of 
time. Some applications were a few years older 
than the others of the same domain or usage area, 
making the core initial MVF between different 
apps irrelevant to compare due to the fast paced 
evolutionary nature of the smartphone application 
market. 
• The version history of the different applications 
varied a lot in level of detail, making it very 
difficult or, even impossible in some cases, to 
accurately identify which features were included in 
the first MVP of certain applications, ultimately 
making a fair comparison unfeasible. 
Hence, we decided that another sample of applications would 
be necessary in order to conduct this data analysis. Another 
filtering criterion would be desirable, including only 
applications with an initial MVP release from the same time 
period and with a highly detailed feature specification, or 
entirely new applications with only one MVP version released 
to the market. This analysis would preferably also require a 
larger sample than the one used for the other analysis, in order 
to reduce validity threats and produce more accurate results 
representing the most common set of MVF for a mHealth 
application in the current market. Given these constraints we 
concluded that the aforementioned research questions edged out 
of scope for this research project and furthermore we decided 
to leave this topic open for future studies.     
D. Validity Threats 
We have only included applications that had a full version 
history available, both in order to categorize what type of 
change that has been made and how the application has evolved 
throughout time, but also to enable us to be as unbiased and fair 
in a comparison with the other applications in our population 
sample as possible when drawing conclusions. However, there 
is a risk that by not systematically include all applications that 
fit our inclusion criteria, nor possibly not having the ability to 
access full version history data of every application, our 
conclusions and theories might be inaccurate and not represent 
the factual case. Furthermore, different developers and 
companies have different ways of describing their application 
updates and changelogs, thus since there is no official “version 
history template” there is a lack of uniformity and the detail 
level of each update varies a lot making it hard to do an accurate 
comparison in some cases. 
Another concern may be that we, as researchers, interpret the 
cause of the change differently when analyzing, which 
jeopardizes making the conclusions and correlations consistent 
and accurate. It should also be taken into consideration that the 
lifetimes of the gathered applications are different; some have a 
long lifespan while others are short lived which might give a 
distorted view of how often an application is updated and which 
technologies that are currently available and might be supported 
or not. The framework for deciding what change can be mapped 
to which cause is not always obvious, some changes can be 
mapped to more than one cause and overlaps several categories 
of change, which might cause inconsistent end results and 
inaccurate conclusions. In summary, the general threats to 
validity in our research consists of:  
• The assessed version history might not be fully 
complete for some of the applications, i.e. other 
updates might exist unknown to us, and thus not 
included in our data samples. 
• Different level of details in the version history of 
different apps. 
• The classification of change drivers might be 
interpreted differently between the researchers. 
• Some changes can be mapped to more than one 
cause. 
• More general classifications of change drivers 
might exist. 
• The applications in our collected sample have 
existed during different time periods. 
• Using only one source for data gathering, i.e. one 
smartphone app market, might render deficient 
results. 
IV. RESULTS 
A. Sample Distribution 
The sample consisted of mobile applications classified into 
the following eight different categories, the dispersion of the 
mobile applications is presented in the table below: 
TABLE I.  SAMPLE DISTRIBUTION OF MOBILE APPLICATIONS 
Category of mobile applications Number of applications 
Diabetes 4 
Diet/Calories 3 
Miscellaneous medical 3 
Woman’s health/Pregnancies 4 
Utility 1 
Entertainment 1 
Finance 2 
Fitness 3 
Total number of mobile applications 21 
 
In this report we have analyzed 21 mobile applications from 
eight different sectors, which were deemed to be sufficient and 
appropriate for the sake of finding out the MVP of a mobile 
health application. 
The pie chart in Fig. 13 represents the different domain 
areas used in this study and the proportion of their respective 
shares of the sample population. Diabetes and women’s health 
are predominant with 19% each, this because of the complete 
and well documented version history we found of these apps. 
At the other end of the spectrum, the non-medical domains such 
as entertainment as well as utility applications only represent 
4,8% each of the total samples used in the study. 
 
 
Figure 13. Domain origins of the total sample of applications used in this study. 
B. Do the release frequency of minimum viable products 
differ between mobile health applications of different 
purposes? 
The horizontal bar chart in Fig. 14 illustrates the release 
ratio between the different mHealth applications analyzed in 
this study. According to our findings, minimum viable products 
of diet/calorie apps as well as diabetic apps are more frequently 
released in new versions than the other medical domains used 
in our sample.  
 
  
Figure 14. The release ratio of the various medical applications used in this 
study.  
Based on the release ratio formula: ! = 	 456758   
Where V = The total number of released versions, D1 = The date of the first 
released MVP and D2 = The date of the latest released MVP: A higher figure 
represents a more frequent continuous delivery of released versions of a MVP.  
 
C. Do the release frequency of minimum viable products 
differ between mobile health applications and mobile 
applications of other domains? 
The horizontal bar chart in Fig. 15 illustrates the average 
release ratio between the mHealth applications and the other 
mobile application domains analyzed in this study.  
 
  
Figure 15. The release ratio of the medical applications domain and the other 
applications used in this study. 
Based on the release ratio formula: ! = 	 456758   
Where V = The total number of released versions, D1 = The date of the first 
released MVP and D2 = The date of the latest released MVP: A higher figure 
represents a more frequent continuous delivery of released versions of a MVP.  
 
D. Do the change frequency of minimum viable products 
differ between mobile health applications of different 
purposes?    
The horizontal bar chart in Fig. 16 represents the average 
number of changes per release of each health application 
domain in this study. Diabetes applications had the most 
changes with 2,84 changes per release, while women’s health 
applications had the lowest amount of changes with 2,67 
changes per release.  
  
 
Figure 16. The average number of changes per release of the various medical 
applications used in this study. 
Based on the change/release ratio formula: ! = 	 94   
Where C = The total number of implemented changes and V = The total number 
of released versions: A higher figure represents a higher mean amount of 
changes implemented in new released versions of the MVP.  
 
E. Do the change frequency of minimum viable products 
differ between mobile health applications and mobile 
applications of other domains? 
The chart in Fig. 17 represents the average number of 
changes per release in the medical domain compared to the 
other domains. We can see that the medical applications had 
slightly more changes with 2,78 changes per release in contrast 
to the utility applications used in this study which had 2,25 
changes per release. 
 
 
Figure 17. The average number of changes per release of the medical 
applications domain and the other applications used in this study. 
Based on the change/release ratio formula: ! = 	 94   
Where C = The total number of implemented changes and V = The total number 
of released versions: A higher figure represents a higher mean amount of 
changes implemented in new released versions of the MVP. 
 
F. Do the factors of the change of the minimum viable 
product differ between mobile health applications of 
different purposes? 
The bar chart in Fig. 18 represents the proportion of 
minimum viable product causes of change within the different 
categories of medical applications. We can see that women’s 
health applications had the most user-experience changes with 
32,3% compared to diabetes applications which had 17,6% 
user-experience related changes. Furthermore, the diabetes 
applications were predominant in performance optimizations 
with 8,8% compared to women’s health applications which 
represented 3,4%. When it comes to bug-fixes we see that the 
diabetes domain had the highest frequency of those with a 
figure of 35,3% compared to the least prominent domain, which 
was the miscellaneous medical applications with 30,4%. 
Compatibility related changes occurred most in the diabetes 
applications with a figure of 7,6% compared to miscellaneous 
medical applications that had 3,8%. Diet and calories 
applications had the most changes related to new features which 
consisted of 28,2% of the total amount of changes compared to 
the women’s health applications which had a figure of 23,8%. 
Moreover, new features enabled by new technological 
possibilities were most common in the diet and calories 
applications, these changes represented 3,9% while diabetes 
applications represented 2,4% at the other end of the spectrum 
of these changes. The changes that were classified as the 
miscellaneous ‘other’ category were insignificant and of such a 
small quantity and therefore left out of numerical 
representations within the bar chart diagram. Furthermore, we 
did not discover any changes at all being related to legislative 
constraints and thus this classification is left out from visual 
presentation in the diagrams.   
 
 
Figure 18. A representation of the minimum viable product cause of change of 
the various categories of medical applications. 
G. Do the factors of the change of the minimum viable 
product differ between mobile health applications and 
mobile applications of other domains? 
The bar chart in Fig. 19 represents the proportion of 
minimum viable product causes of change within the different 
application domains. We can see that fitness applications had 
the most user-experience changes with 46,6% compared to the 
medical applications domain which had 27,4% of user-
experience related changes. Moreover, performance 
optimization was predominant with 10,3% in finance 
applications compared to utility applications which represented 
3,7%. When it comes to bug-fix related changes we see that the 
utility domain had the highest frequency of those with a figure 
of 44,4% compared to the least prominent domain, which was 
the finance applications with 14,4%. The compatibility related 
changes occurred most in the entertainment applications with a 
figure of 26,2% compared to finance applications that had a rate 
of 7,2%. Furthermore, finance applications stood for most of 
the changes related to new features which consisted of 30,9%, 
compared to the utility applications which had a change rate of 
3,7% in this aspect. Additionally, new features enabled by new 
possibilities were predominant in the fitness applications, these 
changes represented 5,5% while finance applications 
represented 2,1% at the other end of the spectrum of these 
changes. The changes that were classified to be driven by the 
‘other’ category were entirely from the medical app domain 
with a figure of 1,4% as no other domains fit into this category 
with the applications from the population we chose. 
 
 
Figure 19. A representation of the cause of change of the MVP in the medical 
applications domain and the other application domains used in this study. 
V. DISCUSSION 
A. How frequent is the continuous development of a MVP of a 
mobile health application? 
Our initial assumption was that the diet and calorie 
applications had more changes than the diabetes applications 
among the medical domain, this because of the complex nature 
of the disease [14]. However, Fig. 16 shows opposite results, 
that among our sample population of the medical domain, the 
diabetes related applications had the highest average number 
with 2,84 changes per release compared to women’s health 
domain which had the lowest average number of 2,67 changes 
per release. With this said it is arguable that the changes per 
release -frequency of minimum viable products does not differ 
between the mobile health applications of different purposes 
used in our research, in any significant way.  
The same result is repeated in Fig. 17 where we can see that 
the medical domain had the highest average number with 2,78 
changes per release compared to the utility domain which had 
the lowest average number of 2,25 changes per release. Based 
on this result we can draw the conclusion that the change 
frequency of minimum viable products does not significantly 
differ between the mobile health applications and the mobile 
applications of other domains used in our research. 
In Fig. 14 we can see that there is a difference in release 
frequency of a minimum viable product in the mHealth domain, 
diet and calories mobile applications has the most frequent 
updates (0,030) among the mHealth applications of our research 
compared to miscellaneous medical which has the least 
frequent updates (0,014). 
When we categorized the mobile applications we 
discovered in the version history of the diet and calorie 
applications that they had often integrated and utilized Apple’s 
HealthKit that was introduced in iOS 8, which is a tool that 
allows developers, with the permission of the user to access 
health data such as how many calories the user has burnt. One 
could imagine that there are new functions and updates released 
from HealthKit frequently and might explain the more recurrent 
updates compared to the other miscellaneous medical 
applications which did not in our study utilize Apple’s 
HealthKit. 
Fig. 15 illustrates that there is indeed a difference in terms 
of release frequency among mHealth applications versus the 
other mobile applications in our study, the medical applications 
had an update rate of 0,021 compared to the utility applications 
which had the most frequent update rate with a value of 0,028. 
However, since we only had one utility application it is hard to 
generalize about the findings, additionally the difference was 
very slight. 
As seen in the horizontal bar chart in Fig. 16 there is a slight 
difference in the amount of changes per release in mHealth 
applications of different purposes used in this study, ranging 
from an average of 2,67 changes per release for women’s 
health/pregnancy applications till 2,84 changes per release for 
diabetes applications. As stated earlier, there is not a huge 
difference in changes per update between the different mHealth 
applications of different purposes in our study, suggesting that 
the change frequency is quite similar. 
Fig. 17 depicts that there is a difference of the change 
frequency between mHealth applications and other mobile 
applications used in this study, where medical applications had 
an average of 2,78 changes per release compared to the lowest 
average value of the finance applications which had 2,36 
changes per release. This result suggests that there is a 
difference between the mHealth domain and the other mobile 
applications of our sample, although the range is quite narrow. 
B. Which factors drive the development of updating a MVP of 
a mobile health application? 
Based on the results in Fig. 18 we can conclude that the 
greatest intervals and biggest gaps of causes of changes within 
medical applications of different purposes lies within the 
categories user-experience and performance optimization. 
Women’s health applications had 32,3% user-experience 
related changes compared to diabetes applications that had only 
17,6%. Regarding the performance optimization of diabetes 
applications, the figure was 8,8% while women’s health 
applications had a value of 3,4% in our study. 
Regarding the noticeable deviating amount of user-
experience related changes in women’s health apps, one 
possible assumption might be that within the women’s health 
apps collected in our sample, many were highly user-interface-
based pregnancy monitoring apps basically consisting of 
graphical visualizations of fetal growth development. 
Additionally, these applications presented a significantly lower 
amount of changes driven by performance-optimization, which 
also might be due to the fact that they mostly consist of more 
illustrative functionality and probably less calculating, thus 
containing algorithms of less complexity, with that being said, 
graphical rendering could obviously imply high performance 
demands as well.   
Furthermore, we can see an even pattern in changes driven 
by bug-fixes and stability enhancements between all mHealth 
domains, ranging from representing 30,9% of all changes in the 
diet/calorie apps to 35,3% in diabetic apps. A possible 
hypothesis could be that the amount of changes driven by bug-
fixes and stability enhancements correlates in parallel to the 
amount of; and the complexity of features that a mHealth 
application provides. However, in contrary to this theory, the 
two mHealth application domains with the highest rate of total 
new features added, happen to be those with the most diverse 
amount of bug-fixes, namely diabetic and diet/calorie apps, 
with 33,5% respectively 33,2% of all MVP changes being 
directly related to added functionality. 
Diabetes apps had the highest amount of compatibility 
related changes, one reason for this might be that these apps are 
granted extended possibilities from new hardware components, 
such as Apple Watch™ being released as smartphone 
accessories, presumably containing sensors for blood pressure 
monitoring, as well as for input of other body-related data. As 
opposed to this theory, however, these apps scored the lowest 
on the classification of changes being driven by new features 
made possible from new technology with 2,4% making this 
assumption more questionable. 
By looking on the results presented in Fig. 19, we can 
conclude a diverse amount of MVP change drivers between all 
domains. In an attempt to answer whether the factors of the 
change of the minimum viable product differ between mobile 
health applications and mobile applications of other domains, 
we can conclude that mHealth applications got very close 
results to entertainment apps in amount of changes driven by 
incentives such as; user-experience improvements, 
performance optimizations, stability enhancements and new 
features made possible from new technology. A major validity 
threat to these findings would however be that our sample only 
consisted of one entertainment app and a larger sample would 
be necessary in order to draw a more accurate conclusion. On 
the other hand, these two categories had very diverse results 
regarding the amount of changes driven by compatibility 
necessities, where financial apps had the closest figure to 
mHealth applications; as well as new features implemented 
with existing technology, where none of the other domains were 
considerably indifferent to mHealth, but with fitness apps being 
closest with a difference of 3,7%.  
In order to further analyze what these findings actually 
mean and thus, conclude if the factors of the change of the 
minimum viable product differ between mobile health 
applications and mobile applications of other domains, it would 
be necessary to study the driving factors of the change of a MVP 
with a more in-depth investigation of every domain included in 
our sample, together with researching the technological 
possibilities available for the current mobile application market.    
VI. SUMMARY 
The purpose with this exploratory case study was to identify 
how mHealth developers deploy their products by applying 
build-measure-learn principles and how frequently they release 
a new minimum-viable-product, but also to analyze which 
factors that triggers the continuous development of those 
products.  
In this study we have shown that there are differences in 
terms of both release frequency, the number of changes per 
release and the driving factors of the change of a minimum-
viable-product, not only between the various mHealth 
applications included in this study but also between those 
applications combined and compared to the other mobile 
application domains that has been examined and assessed in our 
sample. Furthermore, we have introduced and explained 
concepts such as minimum-viable-product, the build-measure-
learn process, lean software development which are all central 
subjects applied in this research topic. 
By finding and categorizing mHealth applications of 
different usage areas and comparing those to mobile 
applications from other domains we have tried to establish 
which factors that drives the development of a minimum viable 
product, how often it is released and how many changes that are 
implemented on average in the different mobile application 
domains. The dispersion of the different domains is presented 
in tables and diagrams to visualize the results and help answer 
our research questions.  
There are however threats to the validity of our findings, 
which has been taken into consideration within the discussion 
of the results, and further research is necessary in order to draw 
more accurate conclusions.  
VII. FUTURE WORK 
In order to draw more accurate conclusions and correlations, 
and to the greatest extent reduce bias, a larger sample of 
applications from the various domains would be needed, as well 
as this could provide enough data to conduct suitable methods 
for statistical analysis, thus improving the accuracy of the 
results.  Moreover, even more domains could be included to get 
a better and fairer overview of what triggers the development of 
a minimum viable product for the mobile health market. Means 
of realizing this could be the use of data triangulation which 
means that we use data from many different sources to get a 
more complete and a broader picture. By using both Google Play 
Store, Apple iTunes and contacting a variety of mobile software 
development companies from different domains we can draw 
better conclusions. Furthermore, we could use methodological 
triangulation with the use of different data collection methods 
such as well formulated surveys and oral interviews, as well as 
data gathering from the online mobile application stores, this in 
turn would yield both quantitative and qualitative data. 
A. What are the most common set of Minimum Viable 
Features (MVF) for a mobile health application? 
Since we did not, as we initially intended, manage to collect 
the data necessary to properly analyze the core minimum viable 
features (MVF) of the different mobile application domains 
targeted in our study: this undiscovered area would be a 
worthwhile topic of future research in the subject, needful in 
order to answer our third set of research questions “What are the 
most common set of Minimum Viable Features (MVF) for a 
mobile health application?”.  
B. How is unwanted functionality detected and dealt with for 
a Minimum Viable Product of mobile health applications? 
Another aspect that would be interesting to look into in 
future research of this subject would be to further study how the 
first step in the concept of ‘Lean Software Development’: 
eliminating waste, is applied by mHealth developers. Which 
initial features are considered unwanted by the users of mobile 
health applications, how are they detected and how quickly are 
they eliminated from the MVP? 
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APPENDIX I. DATA MAPPING SCHEME 
 
Collection date App name Developer App domain Date of first release of MVP Date of latest version Number of versions Lifetime (days)
2016-04-06 Diabetes App - blood sugar control, glucose tracker and carb counter BHI Technologies, Inc. Diabetes 2010-08-21 2013-11-14 9 1181
2016-04-06 DiabetesGuru Shore Innovation HB Diabetes 2014-03-05 2015-05-27 8 448
2016-04-06 Glucose Buddy Azumio Inc. Diabetes 2008-10-28 2012-10-04 20 1437
2016-04-06 mySugr Diabetes mySugr GmbH Diabetes 2015-02-23 2016-03-24 25 395
2016-04-06 Get Moving Epic Pixie KB Diet/Calories 2014-01-10 2015-11-03 18 662
2016-04-06 Lark - Personal Weight Loss Coach & 24/7 Nutrionist LARK Diet/Calories 2014-09-29 2016-03-30 21 548
2016-04-06 Running for Weight Loss interval training plan, GPS, how-to-lose-weight tips by Red Rock Apps GRINASYS CORP. Diet/Calories 2013-07-26 2016-03-18 25 966
2016-04-06 MotionX 24/7 MotionX Misc medical 2012-02-29 2014-11-11 19 986
2016-04-06 Radiology Assistant BestApps BV Misc medical 2010-07-31 2014-12-04 24 1587
2016-04-06 Vision Test Rocktime Ltd Misc medical 2010-07-08 2014-01-13 12 1285
2016-04-06 Cycles - Period tracker with fertility calendar and reminders for both of you. Perigee Woman 2013-02-14 2016-03-15 16 1125
2016-04-06 iPregnant Pregnancy Tracker Free (iPeriod's Pregnancy Companion) Winkpass Creations, Inc. Woman 2011-10-27 2015-02-05 10 1197
2016-04-06 Natural Cycles, the fertility monitor NaturalCycles Nordic AB Woman 2013-12-12 2016-03-17 25 826
2016-04-06 Pregnancy Due Date & Fertility Calculator, Tools and Baby Kick App BabymedLLC Woman 2009-07-18 2015-08-26 14 2230
2016-04-06 Clips - Copy and paste anywhere with widget and keyboard Clean Shaven Apps Utility 2014-10-07 2015-12-17 12 436
2016-04-06 SVT Play Sveriges television AB Entertainment 2010-02-01 2016-03-08 16 2227
2016-04-06 Avanza Avanza Bank AB Finance 2010-07-19 2016-03-11 19 2062
2016-04-06 Nordea Mobilbank - Sverige Nordea Bank Finance 2012-10-29 2015-12-12 22 1139
2016-04-06 CARROT Fit - 7 Minute Workout, Step Counter & Weight Tracker Grailr LLC Fitness 2014-01-24 2015-04-20 12 451
2016-04-06 The Johnsons & Johnson Official 7 Minute Workout App Johnson & Johnson Health and Wellness Solutions, Inc. Fitness 2014-01-03 2016-02-29 13 787
2016-04-06 Workout (7 Minute Body Fitness Excercise) Yellow Lab, Inc. Fitness 2013-05-24 2014-01-16 5 237
Average days between new releases Release ratio No of changes Change/release ratio User-Experience Performance optimization Bug-fix Compatibility New feature (NF) NF from new possibilities Other
131,2 0,008 31 3,44 2 1 16 5 7 0 1
56,0 0,018 23 2,88 4 4 5 3 7 0 1
71,9 0,014 63 3,15 15 8 15 4 21 1 2
15,8 0,063 47 1,88 9 2 24 1 9 3
36,8 0,027 42 2,33 13 12 1 14 3
26,1 0,038 79 3,76 32 3 22 3 22 1
38,6 0,026 60 2,40 22 3 18 5 11 1 1
51,9 0,019 74 3,89 27 14 5 9 19 0
66,1 0,015 51 2,13 17 6 18 7 5 0
107,1 0,009 28 2,33 6 4 9 3 8 0
70,3 0,014 63 3,94 16 8 13 5 22 4
119,7 0,008 22 2,20 5 1 9 5 5 0
33,0 0,030 54 2,16 19 6 10 3 11 3 5
159,3 0,006 33 2,36 4 0 13 2 14 1
36,3 0,028 27 2,25 11 1 12 4 1 1
139,2 0,007 42 2,63 12 4 12 11 5 1
108,5 0,009 42 2,21 25 2 7 3 7 1
51,8 0,019 55 2,50 16 8 7 4 23 1
37,6 0,027 40 3,33 18 5 5 12 3
60,5 0,017 22 1,69 9 3 7 3 5 1
47,4 0,021 11 2,20 7 2 1 4  
